Eusalus Life Science Private Limited
About Eusalus Life Science Private Limited
Data last updated:
Eusalus Life Science Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2016PTC289585. Its GSTIN is 07AAECE1653L1ZK (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sarita Dwivedi and Aman Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rz – 62 G Plot No B – 1 Kh No 21/10 Vashisht Park Pankha Road, New Delhi, Delhi, India – 110046.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.13 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹4.69 Lakh (net margin 1.5%) and EBITDA of ₹7.55 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 94% over three years and 61% over five years.
Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRz – 62 G Plot No B – 1 Kh No 21/10 Vashisht Park Pankha Road, New Delhi, Delhi, India – 110046
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eusalus Life Science Private Limited
The main business activity of Eusalus Life Science is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eusalus Life Science Private Limited FY 2025 filings available
Eusalus Life Science Private Limited reported revenue of ₹3.13 Cr (up 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Eusalus Life Science Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years, including 45% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eusalus Life Science Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.55 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.69 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Eusalus Life Science Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eusalus Life Science are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Eusalus Life Science Private Limited
Eusalus Life Science Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kumudham Pharmacy Private Limited | ₹3.13 Cr (FY 2018) | •••• | •••• | -27.0% | •••• | Coimbatore, Tamil Nadu, India |
| Sanvariya Pharmaceuticals Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Jalore, Rajasthan, India |
| Parth Antibiotics Private Limited | ₹3.13 Cr (FY 2020) | •••• | •••• | 64.0% | •••• | Mumbai, Maharashtra, India |
| Par Pharmaceuticals Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Muzaffarnagar, Uttar Pradesh, India |
| Beauty Beyond Borders Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Eusalus Life Science Private Limited this company | ₹3.13 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | New Delhi, Delhi, India |
| Benzorgo Health Care Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | -51.0% | •••• | Mumbai, Maharashtra, India |
| Zaq Health Care Private Limited | ₹3.12 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Stackwell Industries Private Limited | ₹3.12 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Pune, Maharashtra, India |
| KPK Medical Agency Private Limited | ₹3.11 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Nagpur, Maharashtra, India |
| Agrasar Diagnostic & Healthcare Private Limited | ₹3.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Hoshangabad, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Eusalus Life Science by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Eusalus Life Science Private Limited
Eusalus Life Science Private Limited is audited by ABHISHEK J & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ABHISHEK J & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eusalus Life Science Private Limited
Eusalus Life Science has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarita Dwivedi | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Aman Kumar Mishra | Director | 13 Jan 2016 | 10 Years 9 Months | Current |
Ownership and Shareholding of Eusalus Life Science Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eusalus Life Science Private Limited
Eusalus Life Science Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Eusalus Life Science Private Limited
Eusalus Life Science Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed. Status as checked between 29 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Prayagraj, Uttar Pradesh | Criminal case | Filed against the company by State of U.P | Pending |
| District court, West, Delhi | Civil suit | Filed against the company by State | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Eusalus Life Science Private Limited
Employment history and EPFO contributions of people linked to Eusalus Life Science.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eusalus Life Science Private Limited
Eusalus Life Science Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Shyamsunder Shukla ceased to be Director on 27 Apr 2022.
Credit Ratings, Litigation & Regulatory Alerts for Eusalus Life Science Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eusalus Life Science Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eusalus Life Science Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eusalus Life Science Private Limited
Eusalus Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE1653L1ZK | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eusalus Life Science Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eusalus Life Science Private Limited
Eusalus Life Science is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 January 2016 (10+ years old) and is registered under CIN U51101DL2016PTC289585.
Eusalus Life Science reported revenue of ₹3.13 Cr for FY 2024 (up 45% YoY).
Eusalus Life Science has 2 current directors:
- Sarita Dwivedi - Director
- Aman Kumar Mishra - Director
Eusalus Life Science reported a net profit of ₹4.69 Lakh (net margin 1.5%) and EBITDA of ₹7.55 Lakh (EBITDA margin 2.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eusalus Life Science is 94% over three years and 61% over five years. In the latest year (FY 2024) revenue rose 45%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Eusalus Life Science is 07AAECE1653L1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Eusalus Life Science is U51101DL2016PTC289585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eusalus Life Science has 2 court cases on record: 2 filed against it. 1 is pending.
Eusalus Life Science was incorporated on 13 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Eusalus Life Science by revenue are Kumudham Pharmacy Private Limited, Sanvariya Pharmaceuticals Private Limited, Parth Antibiotics Private Limited, Par Pharmaceuticals Private Limited, Beauty Beyond Borders Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Shyamsunder Shukla ceased to be Director on 27 Apr 2022. Sarita Dwivedi was appointed as Director on 01 Apr 2022. Aman Kumar Mishra was appointed as Director on 13 Jan 2016.